QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

doi: 10.1242/10.1242/jcs.00247

This Article Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Robinson-Rechavi, M. Articles by Laudet, V. Search for Related Content PubMed PubMed Citation Articles by Robinson-Rechavi, M. Articles by Laudet, V. Social Bookmarking                         What's this?

The nuclear receptor superfamily

Laboratoire de Biologie Moléculaire et Cellulaire, UMR CNRS 5665, Ecole Normale Supérieure de Lyon, 46 allée d'Italie, 69364 Lyon Cedex 07, France

^* Author for correspondence (e-mail: marc.robinson{at}ens-lyon.fr)

	Introduction

Top Introduction Canonical structure Diversity of nuclear receptors Mode of action References

 
Nuclear receptors are one of the most abundant classes of transcriptional regulators in animals (metazoans). They regulate diverse functions, such as homeostasis, reproduction, development and metabolism (for a review, see Laudet and Gronemeyer, 2002). Nuclear hormone receptors function as ligand-activated transcription factors, and thus provide a direct link between signaling molecules that control these processes and transcriptional responses. A large number of nuclear receptors have been identified through sequence similarity to known receptors, but have no identified natural ligand, and are referred to as `nuclear orphan receptors'. As nuclear receptors bind small molecules that can easily be modified by drug design, and control functions associated with major diseases (e.g. cancer, osteoporosis and diabetes), they are promising pharmacological targets. The search for ligands for orphan receptors and the identification of novel signaling pathways has become a very active research field (Gustafsson, 1999; Kliewer et al., 1999).

View larger version (51K): [in this window] [in a new window]

	Canonical structure

Top Introduction Canonical structure Diversity of nuclear receptors Mode of action References

 
Nuclear receptors share a common structural organization. The N-terminal region (A/B domain) is highly variable, and contains at least one constitutionally active transactivation region (AF-1) and several autonomous transactivation domains (AD); A/B domains are variable in length, from less than 50 to more than 500 amino acids, and their 3D structure is not known. The most conserved region is the DNA-binding domain (DBD, C domain), which notably contains the P-box, a short motif responsible for DNA-binding specificity on sequences typically containing the AGGTCA motif, and is involved in dimerization of nuclear receptors. This dimerization includes homodimers as well as heterodimers. The 3D structure of the DBD has been resolved for a number of nuclear receptors and contains two highly conserved zinc-fingers — C-X2-C-X13-C-X2-C and C-X5-C-X9-C-X2-C — the four cysteines of each finger chelating one Zn²⁺ ion. The structure represented shows the DBD of the human glucocorticoid receptor (GR) binding to DNA (Hard et al., 1990). Between the DNA-binding and ligand-binding domains is a less conserved region (D domain) that behaves as a flexible hinge between the C and E domains, and contains the nuclear localization signal (NLS), which may overlap on the C domain. The largest domain is the moderately conserved ligand-binding domain (LBD, E domain), whose secondary structure of 12 -helixes is better conserved than the primary sequence. The 3D structure has been determined for several nuclear receptors (reviewed by Moras and Gronemeyer, 1998), unliganded (apo) or liganded (holo), allowing much better understanding of the mechanisms involved in ligand binding. We show the LBD of RXR in apo form (Bourguet et al., 1995) and in holo form with its natural ligand 9-cis retinoic acid (Egea et al., 2000) (figures courtesy of Jean-Marie Wurtz, Institut de Génétique et de Biologie Moléculaire et Cellulaire, Illkirch, France). The E domain is responsible for many functions, mostly ligand induced, notably the AF-2 transactivation function, a strong dimerization interface, another NLS, and often a repression function. Nuclear receptors may or may not contain a final domain in the C-terminus of the E domain, the F domain, whose sequence is extremely variable and whose structure and function are unknown.

	Diversity of nuclear receptors

Top Introduction Canonical structure Diversity of nuclear receptors Mode of action References

 
Nuclear receptors form a superfamily of phylogenetically related proteins, with 21 genes in the complete genome of the fly Drosophila melanogaster (Adams et al., 2000), 48 in humans (Robinson-Rechavi et al., 2001) [but one more, FXRß, in the mouse (Robinson-Rechavi and Laudet, 2003)] and, unexpectedly, more than 270 genes in the nematode worm Caenorhabditis elegans (Sluder et al., 1999). This diversity has been organized in a phylogeny-based nomenclature (Nuclear Receptors Nomenclature Committee, 1999) of the form NRxyz, where x is the sub-family, y is the group and z the gene. In addition to nuclear receptors that have both DNA-binding and ligand-binding domains, sub-family NR0 contains weird nuclear receptors that lack either of these domains, and are not represented in the phylogenetic tree. They include notably Knirps, KNRL and EGON (NR0A1, 2, 3) in Drosophila, and DAX1 and SHP (NR0B1, 2) in vertebrates.

The superfamily includes receptors for hydrophobic molecules such as steroid hormones (e.g. estrogens, glucocorticoids, progesterone, mineralocorticoids, androgens, vitamin D3, ecdysone, oxysterols and bile acids), retinoic acids (all-trans and 9-cis isoforms), thyroid hormones, fatty acids, leukotrienes and prostaglandins (Escriva et al., 2000; Laudet and Gronemeyer, 2002). RXRs (USP in arthropods, indicated by a red dot in the phylogeny) play a central role in dimerization of nuclear receptors, and we have indicated its partners by a red star in the phylogenetic tree (for a review, see Laudet and Gronemeyer, 2002); the stars with a question mark indicate the controversial description of hetero-dimerization of COUP-TF with RXR, and the lack of information on FXRß.

	Mode of action

Top Introduction Canonical structure Diversity of nuclear receptors Mode of action References

 
Nuclear receptors classically act in three steps (reviewed by Laudet and Gronemeyer, 2002): repression, derepression and transcription activation. Repression is characteristic of the apo-nuclear receptor, which recruits a corepressor complex with histone deacetylase activity (HDAC; represented in the lower half of the bottom-right inset). Derepression occurs following ligand binding, which dissociates this complex and recruits a first coactivator complex, with histone acetyltransferase (HAT) activity, resulting in chromatin decondensation, which is believed to be necessary but not sufficient for activation of the target gene. In the third step, the HAT complex dissociates and a second coactivator complex is assembled (TRAP/DRIP/ARC), which is able to establish contact with the basal transcription machinery, and thus results in transcription activation of the target gene. This is of course a very schematic view, and the precise order of events is still debated. It should also be noted that this mechanism is not general, since some nuclear receptors may act as activators without a ligand, whereas others are unable to interact with the target gene promoter in the absence of ligand (the `repression' step).

	References

Top Introduction Canonical structure Diversity of nuclear receptors Mode of action References

 

Adams, M. D., Celniker, S. E., Holt, R. A., Evans, C. A., Gocayne, J. D., Amanatides, P. G., Scherer, S. E., Li, P. W., Hoskins, R. A., Galle, R. F. et al. (2000). The genome sequence of Drosophila melanogaster. Science 287,2185 -2195.[Abstract/Free Full Text]

Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H. and Moras, D. (1995). Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-. Nature 375,377 -382.[CrossRef][Medline]

Egea, P. F., Mitschler, A., Rochel, N., Ruff, M., Chambon, P. and Moras, D. (2000). Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J. 19,2592 -2601.[CrossRef][Medline]

Escriva, H., Delaunay, F. and Laudet, V. (2000). Ligand binding and nuclear receptor evolution. Bioessays 22,717 -727.[CrossRef][Medline]

Gustafsson, J. A. (1999). Seeking ligands for lonely orphan receptors. Science 284,1285 -1286.[Free Full Text]

Hard, T., Kellenbach, E., Boelens, R., Maler, B. A., Dahlman, K., Freedman, L. P., Carlstedt-Duke, J., Yamamoto, K. R., Gustafsson, J. A. and Kaptein, R. (1990). Solution structure of the glucocorticoid receptor DNA-binding domain. Science 249,157 -160.[Abstract/Free Full Text]

Kliewer, S. A., Lehmann, J. M. and Willson, T. M. (1999). Orphan nuclear receptors: shifting endocrinology into reverse. Science 284,757 -760.[Abstract/Free Full Text]

Laudet, V. and Gronemeyer, H. (2002).The nuclear receptors factsbook . London: Academic Press.

Moras, D. and Gronemeyer, H. (1998). The nuclear receptor ligand-binding domain: structure and function. Curr. Opin. Cell Biol. 10,384 -391.[CrossRef][Medline]

Nuclear Receptors Nomenclature Committee (1999). A unified nomenclature system for the nuclear receptor superfamily. Cell 97,1 -3.[CrossRef][Medline]

Robinson-Rechavi, M., Carpentier, A.-S., Duffraisse, M. and Laudet, V. (2001). How many nuclear hormone receptors in the human genome? Trends Genet 17,554 -556.[CrossRef][Medline]

Robinson-Rechavi, M. and Laudet, V. (2003). Bioinformatics of nuclear receptors. Methods Enzymol. (in press).

Sluder, A. E., Mathews, S. W., Hough, D., Yin, V. P. and Maina, C. V. (1999). The nuclear receptor superfamily has undergone extensive proliferation and diversification in nematodes. Genome Research 9,103 -120.[Abstract/Free Full Text]

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

Related articles in JCS:

A guide to nuclear receptors

JCS 2003 116: 406. [Full Text]  

This article has been cited by other articles:

				B. M. Stenson, M. Ryden, K. R. Steffensen, K. Wahlen, A. T. Pettersson, J. W. Jocken, P. Arner, and J. Laurencikiene Activation of Liver X Receptor Regulates Substrate Oxidation in White Adipocytes Endocrinology, September 1, 2009; 150(9): 4104 - 4113. [Abstract] [Full Text] [PDF]

				R. Parlato, C. Otto, J. Tuckermann, S. Stotz, S. Kaden, H.-J. Grone, K. Unsicker, and G. Schutz Conditional Inactivation of Glucocorticoid Receptor Gene in Dopamine-{beta}-Hydroxylase Cells Impairs Chromaffin Cell Survival Endocrinology, April 1, 2009; 150(4): 1775 - 1781. [Abstract] [Full Text] [PDF]

				L.-j. Zhang, X. Liu, P. R. Gafken, C. Kioussi, and M. Leid A Chicken Ovalbumin Upstream Promoter Transcription Factor I (COUP-TFI) Complex Represses Expression of the Gene Encoding Tumor Necrosis Factor {alpha}-induced Protein 8 (TNFAIP8) J. Biol. Chem., March 6, 2009; 284(10): 6156 - 6168. [Abstract] [Full Text] [PDF]

				A. B Ropero, P. Juan-Pico, A. Rafacho, E. Fuentes, F J. Bermudez-Silva, E. Roche, I. Quesada, F. R. de Fonseca, and A. Nadal Rapid non-genomic regulation of Ca2+ signals and insulin secretion by PPAR{alpha} ligands in mouse pancreatic islets of Langerhans J. Endocrinol., February 1, 2009; 200(2): 127 - 138. [Abstract] [Full Text] [PDF]

				S. Denger, T. Bahr-Ivacevic, H. Brand, G. Reid, J. Blake, M. Seifert, C.-Y. Lin, K. May, V. Benes, E. T. Liu, et al. Transcriptome Profiling of Estrogen-Regulated Genes in Human Primary Osteoblasts Reveals an Osteoblast-Specific Regulation of the Insulin-Like Growth Factor Binding Protein 4 Gene Mol. Endocrinol., February 1, 2008; 22(2): 361 - 379. [Abstract] [Full Text] [PDF]

				V. Bourdeau, J. Deschenes, D. Laperriere, M. Aid, J. H. White, and S. Mader Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells Nucleic Acids Res., January 17, 2008; 36(1): 76 - 93. [Abstract] [Full Text] [PDF]

				A. Germaniuk-Kurowska, A. Nag, X. Zhao, M. Dimri, H. Band, and V. Band Ada3 Requirement for HAT Recruitment to Estrogen Receptors and Estrogen-Dependent Breast Cancer Cell Proliferation Cancer Res., December 15, 2007; 67(24): 11789 - 11797. [Abstract] [Full Text] [PDF]

				A. D. Bird, K. H. Tan, P. F. Olsson, M. Zieba, S. J. Flecknoe, D. R. Liddicoat, R. Mollard, S. B. Hooper, and T. J. Cole Identification of glucocorticoid-regulated genes that control cell proliferation during murine respiratory development J. Physiol., November 15, 2007; 585(1): 187 - 201. [Abstract] [Full Text] [PDF]

				J. Deschenes, V. Bourdeau, J. H. White, and S. Mader Regulation of GREB1 Transcription by Estrogen Receptor {alpha} through a Multipartite Enhancer Spread Over 20 kb of Upstream Flanking Sequences J. Biol. Chem., June 15, 2007; 282(24): 17335 - 17339. [Abstract] [Full Text] [PDF]

				D. Nguyen, M. Bail, G. Pesant, V. N. Dupont, E. Rouault, J. Deschenes, W. Rocha, G. Melancon, S. V. Steinberg, and S. Mader Rational design of an estrogen receptor mutant with altered DNA-binding specificity Nucleic Acids Res., May 11, 2007; 35(10): 3465 - 3477. [Abstract] [Full Text] [PDF]

				A. Haelens, T. Tanner, S. Denayer, L. Callewaert, and F. Claessens The Hinge Region Regulates DNA Binding, Nuclear Translocation, and Transactivation of the Androgen Receptor Cancer Res., May 1, 2007; 67(9): 4514 - 4523. [Abstract] [Full Text] [PDF]

				K. P. Madauss, E. T. Grygielko, S.-J. Deng, A. C. Sulpizio, T. B. Stanley, C. Wu, S. A. Short, S. K. Thompson, E. L. Stewart, N. J. Laping, et al. A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator Mol. Endocrinol., May 1, 2007; 21(5): 1066 - 1081. [Abstract] [Full Text] [PDF]

				M. Lupien, M. Jeyakumar, E. Hebert, K. Hilmi, D. Cotnoir-White, C. Loch, A. Auger, G. Dayan, G.-A. Pinard, J.-M. Wurtz, et al. Raloxifene and ICI182,780 Increase Estrogen Receptor-{alpha} Association with a Nuclear Compartment via Overlapping Sets of Hydrophobic Amino Acids in Activation Function 2 Helix 12 Mol. Endocrinol., April 1, 2007; 21(4): 797 - 816. [Abstract] [Full Text] [PDF]

				G. Amoutzias, A. Veron, J Weiner III, M Robinson-Rechavi, E Bornberg-Bauer, S. Oliver, and D. Robertson One Billion Years of bZIP Transcription Factor Evolution: Conservation and Change in Dimerization and DNA-Binding Site Specificity Mol. Biol. Evol., March 1, 2007; 24(3): 827 - 835. [Abstract] [Full Text] [PDF]

				L. Palanker, A. S. Necakov, H. M. Sampson, R. Ni, C. Hu, C. S. Thummel, and H. M. Krause Dynamic regulation of Drosophila nuclear receptor activity in vivo Development, September 15, 2006; 133(18): 3549 - 3562. [Abstract] [Full Text] [PDF]

				G. Dayan, M. Lupien, A. Auger, S. I. Anghel, W. Rocha, S. Croisetiere, J. A. Katzenellenbogen, and S. Mader Tamoxifen and Raloxifene Differ in Their Functional Interactions with Aspartate 351 of Estrogen Receptor {alpha} Mol. Pharmacol., August 1, 2006; 70(2): 579 - 588. [Abstract] [Full Text] [PDF]

				L. A. Helguero, M. Hedengran Faulds, C. Forster, J.-A. Gustafsson, and L.-A. Haldosen DAX-1 Expression Is Regulated during Mammary Epithelial Cell Differentiation Endocrinology, July 1, 2006; 147(7): 3249 - 3259. [Abstract] [Full Text] [PDF]

				C. Phelps, V. Gburcik, E. Suslova, P. Dudek, F. Forafonov, N. Bot, M. MacLean, R. J. Fagan, and D. Picard Fungi and animals may share a common ancestor to nuclear receptors PNAS, May 2, 2006; 103(18): 7077 - 7081. [Abstract] [Full Text] [PDF]

				Y. Ogura, M. Azuma, Y. Tsuboi, Y. Kabe, Y. Yamaguchi, T. Wada, H. Watanabe, and H. Handa TFII-I down-regulates a subset of estrogen-responsive genes through its interaction with an initiator element and estrogen receptor {alpha} Genes Cells, April 1, 2006; 11(4): 373 - 381. [Abstract] [Full Text] [PDF]

				N. Ouyang, J. L. Williams, and B. Rigas NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR){delta} expression in APCmin/+ mice proportionally to their tumor inhibitory effect: Implications for the role of PPAR{delta} in carcinogenesis Carcinogenesis, February 1, 2006; 27(2): 232 - 239. [Abstract] [Full Text] [PDF]

				H. L. D. Brown, L. Cherbas, P. Cherbas, and J. W. Truman Use of time-lapse imaging and dominant negative receptors to dissect the steroid receptor control of neuronal remodeling in Drosophila Development, January 15, 2006; 133(2): 275 - 285. [Abstract] [Full Text] [PDF]

				L. Callewaert, N. Van Tilborgh, and F. Claessens Interplay between Two Hormone-Independent Activation Domains in the Androgen Receptor Cancer Res., January 1, 2006; 66(1): 543 - 553. [Abstract] [Full Text] [PDF]

				M. Chen, S. Beaven, and P. Tontonoz Identification and characterization of two alternatively spliced transcript variants of human liver X receptor alpha J. Lipid Res., December 1, 2005; 46(12): 2570 - 2579. [Abstract] [Full Text] [PDF]

				P. Gu, D. H. Morgan, M. Sattar, X. Xu, R. Wagner, M. Raviscioni, O. Lichtarge, and A. J. Cooney Evolutionary Trace-based Peptides Identify a Novel Asymmetric Interaction That Mediates Oligomerization in Nuclear Receptors J. Biol. Chem., September 9, 2005; 280(36): 31818 - 31829. [Abstract] [Full Text] [PDF]

				M. E. Baker Xenobiotics and the Evolution of Multicellular Animals: Emergence and Diversification of Ligand-Activated Transcription Factors Integr. Comp. Biol., January 1, 2005; 45(1): 172 - 178. [Abstract] [Full Text] [PDF]

				V. Bourdeau, J. Deschenes, R. Metivier, Y. Nagai, D. Nguyen, N. Bretschneider, F. Gannon, J. H. White, and S. Mader Genome-Wide Identification of High-Affinity Estrogen Response Elements in Human and Mouse Mol. Endocrinol., June 1, 2004; 18(6): 1411 - 1427. [Abstract] [Full Text] [PDF]

				M. Bhasin and G. P. S. Raghava Classification of Nuclear Receptors Based on Amino Acid Composition and Dipeptide Composition J. Biol. Chem., May 28, 2004; 279(22): 23262 - 23266. [Abstract] [Full Text] [PDF]

				T. J. Cole, N. M. Solomon, R. Van Driel, J. A. Monk, D. Bird, S. J. Richardson, R. J. Dilley, and S. B. Hooper Altered Epithelial Cell Proportions in the Fetal Lung of Glucocorticoid Receptor Null Mice Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 613 - 619. [Abstract] [Full Text] [PDF]

This Article Figures Only Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Robinson-Rechavi, M. Articles by Laudet, V. Search for Related Content PubMed PubMed Citation Articles by Robinson-Rechavi, M. Articles by Laudet, V. Social Bookmarking                         What's this?